A Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor

Conditions: TMB-H; Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors Interventions: Drug: IMC-001 Sponsors: ImmuneOncia Therapeutics Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06365840

Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials

More News: Cytology | Research | Study